Is Freeport-McMoRan’s (FCX) Earnings Resilience Undervalued As Forecasts Double Versus Last Year?
Freeport-McMoRan, Inc. FCX | 0.00 |
- Recently, analysts highlighted that Freeport-McMoRan is projected to deliver quarterly earnings per share around double the prior year, after repeatedly beating revenue and EPS estimates in past reports.
- This combination of stronger profit expectations and a history of outperforming forecasts has intensified investor focus on how resilient its earnings power may be.
- We’ll now examine how this expectation of sharply higher quarterly earnings influences Freeport-McMoRan’s existing investment narrative and risk balance.
AI is about to change healthcare. These 36 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Freeport-McMoRan Investment Narrative Recap
To own Freeport-McMoRan, you need to believe in the long-term value of its copper and gold assets despite operational, regulatory, and commodity-price uncertainty. The recent expectation that quarterly EPS could roughly double versus last year sharpens attention on near term earnings sensitivity, but does not fundamentally change the central catalyst of copper pricing or the key risk tied to complex, policy exposed operations in Indonesia.
Against this backdrop, the board’s decision on 25 March 2026 to affirm a US$0.15 per share quarterly dividend, with both base and variable components, stands out. It underscores how current cash generation is being shared with shareholders even as consensus earnings forecasts adjust, linking the latest EPS momentum to Freeport-McMoRan’s performance based payout framework and its appeal for investors who care about income alongside commodity exposure.
Yet, in contrast to the upbeat earnings story, investors should also be aware of how prolonged reliance on Indonesian assets could expose them to shifting government policies and...
Freeport-McMoRan's narrative projects $35.7 billion revenue and $5.3 billion earnings by 2029. This requires 11.3% yearly revenue growth and a $3.1 billion earnings increase from $2.2 billion today.
Uncover how Freeport-McMoRan's forecasts yield a $67.40 fair value, in line with its current price.
Exploring Other Perspectives
While the latest EPS beat grabs attention, remember some analysts were expecting only about US$29.7 billion of revenue and US$2.3 billion of earnings by 2028, which reflects a much more cautious view than consensus and may need revisiting as this new earnings data comes through.
Explore 6 other fair value estimates on Freeport-McMoRan - why the stock might be worth as much as 22% more than the current price!
Form Your Own Verdict
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Freeport-McMoRan research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Freeport-McMoRan research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Freeport-McMoRan's overall financial health at a glance.
Looking For Alternative Opportunities?
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
- Capitalize on the AI infrastructure supercycle with our selection of the 36 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 19 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- Uncover the next big thing with 32 elite penny stocks that balance risk and reward.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
